Catalyst Wire Dossier Catalyst Wire Dossier

Astepro 0.1% Nasal Spray

azelastine · Meda Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Astepro 0.1% Nasal Spray, covering 2015-06-29 to 2015-06-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR [Phase 4]

See pricing